Literature DB >> 29856983

Soft agar-based selection of spontaneously transformed rat prostate epithelial cells with highly tumorigenic characteristics.

Martina Šrajer Gajdošik1, Douglas C Hixson2, Kate E Brilliant3, DongQin Yang3, Monique E De Paepe4, Djuro Josić5, David R Mills6.   

Abstract

The critical molecular and cellular mechanisms involved in the development and progression of prostate cancer remain elusive. In this report, we demonstrate that normal rat prostate epithelial cells (PEC) undergo spontaneous transformation at high passage (p > 85) evidenced by the acquisition of anchorage independent growth when plated on soft agar and tumorigenicity when injected into immunodeficient mice. In addition, we also report the discovery of a minor subpopulation of spontaneously transformed PEC derived from high passage PEC with the ability to migrate through a layer of 1% agar and form expanding colonies on the underlying plastic substratum. Comparison of these soft agar invasive (SAI) cells with low (p < 35), mid (p36-84) and high passage (p > 85) PEC identified marked differences in cell morphology, proliferation and motility. The SAI subpopulation was more tumorigenic than the high passage anchorage independent cultures from which they were isolated, as manifested by a decreased latency period and an increase in the size of tumors arising in immunodeficient mice. In contrast, low and mid passage cells were unable to grow on soft agar and failed to form tumors when injected into immunodeficient mice. Screening with antibody-based signaling arrays identified several differences in the altered expression levels of signaling proteins between SAI-derived cells and low or high passage PEC, including the up-regulation of EGFR and MAPK-related signaling pathways in SAI-selected cells. In summary, these studies suggest that the SAI assay selects for a novel, highly tumorigenic subpopulation of transformed cells that may represent an early step in the progression of slow growing prostatic carcinomas into more rapidly growing and aggressive tumors.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer stem cell; Neoplastic conversion; Prostate epithelial cells; Tumorigenicity

Mesh:

Substances:

Year:  2018        PMID: 29856983      PMCID: PMC6071870          DOI: 10.1016/j.yexmp.2018.05.014

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  37 in total

1.  Analysis of microarray data using Z score transformation.

Authors:  Chris Cheadle; Marquis P Vawter; William J Freed; Kevin G Becker
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

2.  PROSTATE CANCER IN THE RAT.

Authors:  W F DUNNING
Journal:  Natl Cancer Inst Monogr       Date:  1963-10

3.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

4.  Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells.

Authors:  N H Colburn; W F Bruegge; J R Bates; R H Gray; J D Rossen; W H Kelsey; T Shimada
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

5.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

6.  Long-term culture and characteristics of normal rat liver bile duct epithelial cells.

Authors:  L Yang; R A Faris; D C Hixson
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

7.  Monoclonal antibodies recognizing oval cells induced in the liver of rats by N-2-fluorenylacetamide or ethionine in a choline-deficient diet.

Authors:  D C Hixson; J P Allison
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

8.  Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.

Authors:  Sergio Rutella; Giuseppina Bonanno; Annabella Procoli; Andrea Mariotti; Maria Corallo; Maria Grazia Prisco; Adriana Eramo; Chiara Napoletano; Daniela Gallo; Alessandro Perillo; Marianna Nuti; Luca Pierelli; Ugo Testa; Giovanni Scambia; Gabriella Ferrandina
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

9.  Identification and expansion of the tumorigenic lung cancer stem cell population.

Authors:  A Eramo; F Lotti; G Sette; E Pilozzi; M Biffoni; A Di Virgilio; C Conticello; L Ruco; C Peschle; R De Maria
Journal:  Cell Death Differ       Date:  2007-11-30       Impact factor: 15.828

10.  Signaling pathway switch in breast cancer.

Authors:  Arnaud Guille; Max Chaffanet; Daniel Birnbaum
Journal:  Cancer Cell Int       Date:  2013-06-27       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.